CN106492214A - A kind of Immune Profile In Chicks method - Google Patents

A kind of Immune Profile In Chicks method Download PDF

Info

Publication number
CN106492214A
CN106492214A CN201610933889.8A CN201610933889A CN106492214A CN 106492214 A CN106492214 A CN 106492214A CN 201610933889 A CN201610933889 A CN 201610933889A CN 106492214 A CN106492214 A CN 106492214A
Authority
CN
China
Prior art keywords
chickling
days
ages
vaccines
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610933889.8A
Other languages
Chinese (zh)
Inventor
杨明军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610933889.8A priority Critical patent/CN106492214A/en
Publication of CN106492214A publication Critical patent/CN106492214A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention discloses a kind of Immune Profile In Chicks method, comprises the following steps that：35 ages in days, using ma5+cl30 vaccines to chickling eye dripping；8 10 ages in days, every 0.2 0.4ml newcastle inactivated vaccine of chickling cervical region subcutaneous injection；12 14 ages in days, from fabricius bursa ch80 vaccines to chickling drip；17 19 ages in days, every 0.3 0.4ml avian influenza vaccine of chickling cervical region subcutaneous injection；22 24 ages in days, again with fabricius bursa ch80 vaccines to chickling drip；28 30 ages in days, two exempt from using ma5+cl30 vaccines to chickling eye dripping；40 ages in days, select infectiousness larynx trachea vaccine to chickling eye dripping.The present invention injects different vaccines and chickling is inoculated with, reduce chicken in growth course in chickling different days, and the sickness rate of various diseases improves the income of raiser.

Description

A kind of Immune Profile In Chicks method
Technical field
The present invention relates to a kind of Immune Profile In Chicks method, is applied to chickling Cultivating techniques field.
Background technology
Chickling is referred to from the chicken for going out shell to 6 week old, during cultivation chicken, can be because the shadow of environment and the source of infection Ring, chicken has an aptitude to various disease in different growth stage, therefore need to be in chick stage to a series of vaccines of chicken inoculation, to drop There is the probability of disease in low later stage chicken, but still also do not have a kind of very perfect immunization method in the market, therefore can be to supporting Grow family and bring certain economic loss.
Content of the invention
Above-mentioned for solving the problems, such as, the invention discloses a kind of Immune Profile In Chicks method, systematicness is high, good immune effect.
The invention discloses a kind of Immune Profile In Chicks method, comprises the following steps that：
Step one：3-5 ages in days, using ma5+cl30 vaccines to chickling eye dripping；
Step 2：8-10 ages in days, every chickling cervical region subcutaneous injection 0.2-0.4ml newcastle inactivated vaccine；
Step 3：12-14 ages in days, from fabricius bursa ch80 vaccines to chickling drip；
Step 4：17-19 ages in days, every chickling cervical region subcutaneous injection 0.3-0.4ml avian influenza vaccine；
Step 5：22-24 ages in days, again with fabricius bursa ch80 vaccines to chickling drip；
Step 6：28-30 ages in days, two exempt from using ma5+cl30 vaccines to chickling eye dripping；
Step 7：40 ages in days, select infectiousness larynx trachea vaccine to chickling eye dripping.
The technical program is adopted, the invention has the beneficial effects as follows：In chickling different days, different vaccines are injected to chickling Being inoculated with, chicken being reduced in growth course, the sickness rate of various diseases is improve the income of raiser.
Specific embodiment
In order that technological means, creation characteristic, reached purpose and effect that the present invention is realized are easy to understand, tie below Specific embodiment is closed, the present invention is expanded on further.
Embodiment one：
The invention discloses a kind of Immune Profile In Chicks method, comprises the following steps that：
Step one：3 ages in days, using ma5+cl30 vaccines to chickling eye dripping；
Step 2：8 ages in days, every chickling cervical region subcutaneous injection 0.3ml newcastle inactivated vaccine；
Step 3：12 ages in days, from fabricius bursa ch80 vaccines to chickling drip；
Step 4：17 ages in days, every chickling cervical region subcutaneous injection 0.3ml avian influenza vaccine；
Step 5：22 ages in days, again with fabricius bursa ch80 vaccines to chickling drip；
Step 6：28 ages in days, two exempt from using ma5+cl30 vaccines to chickling eye dripping；
Step 7：40 ages in days, select infectiousness larynx trachea vaccine to chickling eye dripping.
Embodiment two：
The invention discloses a kind of Immune Profile In Chicks method, comprises the following steps that：
Step one：4 ages in days, using ma5+cl30 vaccines to chickling eye dripping；
Step 2：9 ages in days, every chickling cervical region subcutaneous injection 0.4ml newcastle inactivated vaccine；
Step 3：13 ages in days, from fabricius bursa ch80 vaccines to chickling drip；
Step 4：18 ages in days, every chickling cervical region subcutaneous injection 0.4ml avian influenza vaccine；
Step 5：13 ages in days, again with fabricius bursa ch80 vaccines to chickling drip；
Step 6：19 ages in days, two exempt from using ma5+cl30 vaccines to chickling eye dripping；
Step 7：40 ages in days, select infectiousness larynx trachea vaccine to chickling eye dripping.
Finally it should be noted that：Above example only not limits technology described in the invention in order to the present invention to be described Scheme；Therefore, although this specification with reference to each above-mentioned embodiment to present invention has been detailed description, this Field it is to be appreciated by one skilled in the art that still can modify to the present invention or equivalent；And all are without departing from this The technical scheme of the spirit and scope of invention and its improvement, its all should be covered in scope of the presently claimed invention.

Claims (1)

1. a kind of Immune Profile In Chicks method, it is characterised in that comprise the following steps that：
Step one：3-5 ages in days, using ma5+cl30 vaccines to chickling eye dripping；
Step 2：8-10 ages in days, every chickling cervical region subcutaneous injection 0.2-0.4ml newcastle inactivated vaccine；
Step 3：12-14 ages in days, from fabricius bursa ch80 vaccines to chickling drip；
Step 4：17-19 ages in days, every chickling cervical region subcutaneous injection 0.3-0.4ml avian influenza vaccine；
Step 5：22-24 ages in days, again with fabricius bursa ch80 vaccines to chickling drip；
Step 6：28-30 ages in days, two exempt from using ma5+cl30 vaccines to chickling eye dripping；
Step 7：40 ages in days, select infectiousness larynx trachea vaccine to chickling eye dripping.
CN201610933889.8A 2016-10-25 2016-10-25 A kind of Immune Profile In Chicks method Withdrawn CN106492214A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610933889.8A CN106492214A (en) 2016-10-25 2016-10-25 A kind of Immune Profile In Chicks method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610933889.8A CN106492214A (en) 2016-10-25 2016-10-25 A kind of Immune Profile In Chicks method

Publications (1)

Publication Number Publication Date
CN106492214A true CN106492214A (en) 2017-03-15

Family

ID=58319845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610933889.8A Withdrawn CN106492214A (en) 2016-10-25 2016-10-25 A kind of Immune Profile In Chicks method

Country Status (1)

Country Link
CN (1) CN106492214A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107787914A (en) * 2017-10-26 2018-03-13 绿春县农业园林生态有限责任公司 The method for breeding of Lvchun County coptis chicken

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343875A (en) * 2015-10-21 2016-02-24 颍上县嘉鸣蛋鸡养殖有限公司 Growing chicken immunization method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105343875A (en) * 2015-10-21 2016-02-24 颍上县嘉鸣蛋鸡养殖有限公司 Growing chicken immunization method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李建伟: "不同疫苗和接种方式对雏鸡免疫应激反应的研究", 《中国优秀硕士学位论文全文数据库（电子期刊）》 *
王彦银: "雏鸡滴鼻点眼免疫法", 《养殖与饲料 》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107787914A (en) * 2017-10-26 2018-03-13 绿春县农业园林生态有限责任公司 The method for breeding of Lvchun County coptis chicken

Similar Documents

Publication Publication Date Title
CN101695573B (en) Method for producing pseudorabies living vaccines by using subculture cell source and product thereof
CN104126506B (en) A kind of method for tissue culture of American Red rocket Lagerstroemia indica L.
CN106492214A (en) A kind of Immune Profile In Chicks method
CN103548691B (en) The method of tea-tree tissue culture seedling culture of rootage
CN104855305A (en) Laying hen immune process
CN105343875A (en) Growing chicken immunization method
RU2019137459A (en) Vaccines Based on Bird Reoviruses
CN105475143A (en) Method for obtaining regenerated plant through longtube stonegarlic tissue culture
CN109385385B (en) Preparation method and application of mycoplasma avium culture medium and mycoplasma avium bacterial liquid
US10124057B2 (en) Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck
CN104521559B (en) Factory-like bottle-cultivation hypsizygus marmoreus growth stage carbon dioxide concentration control method
CN106267176B (en) Infectious coryza vaccine composition, preparation method and application thereof
CN106798919A (en) A kind of goat immune method
CN101697709A (en) Method for increasing taxol content in yew in south China
CN103999774B (en) A kind of formula of roxburgh anoectochilus terminal bud stem with bud tissue cultures forming seedling through one step culture
CN104782494A (en) Thymus mongolicus Ronn. tissue culture rapid propagation method
MX2023000173A (en) Process for preparing shelf-stable plant-based yogurt analogues and yogurt analogues thereof.
MX2022016176A (en) Cell line for production of marek's disease virus vaccine and methods of making and using the same.
CN105379562A (en) Method for cultivating sterile silkworm insect grass
CN106344916A (en) Method of immunization of broilers90ip['
CN103355171A (en) Tissue culture method of dwarf radix ophiopogonis
CN106620688A (en) Breed duck immunization method
CN105920597A (en) Immunization method of high-yielding laying hens
CN108901585A (en) A kind of front and back of needle mushroom bacterium germination cultural method stage by stage
CN103734004A (en) Preparation method of magnolia biloba bud induction culture medium

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170315